UNSPSC 51101687: Sulnidazole

This classification denotes an antiprotozoal agent with the molecular formula C9H14N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 504LR309YV, chemically known as r 26,412 but generally known as sulnidazole, which bears US NIH Compound Identifier 3037172. European Medicines Agency schedules Sulnidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10750MIG.

UNSPSC 51101687 Sulnidazole, a Commodity code, nominally covers a specific antiprotozoal pharmaceutical ingredient, but recent state and local procurement activity under this code shows limited direct relevance to the code's stated scope. State and local health agencies and counties do procure pharmaceuticals through cooperative purchasing vehicles and direct contracts, but the two most recent opportunities posted under this code — an Illinois Department of Public Health piggyback pharmaceutical warehouse order for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and Safe Drug Deactivation Systems — do not center on sulnidazole itself. These solicitations suggest that state and local buyers use this code's taxonomy classification more broadly to tag pharmaceutical supply agreements, including antibiotics and emergency-response medications, rather than narrowly to sulnidazole-specific purchases. Issuing bodies include state health departments and county health authorities pursuing pharmaceutical supply through IFB processes and cooperative purchasing consortia such as MMCAP.

The geographic spread evident in recent postings includes Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 contract over three years to Chartwell Rx LLC through the MMCAP Infuse cooperative purchasing vehicle following an IFB process with a response date of September 11, 2026. Seminole County, Florida released an IFB on June 30, 2026 for 1,900 annual units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building, though the posted response deadline of July 26, 2023 appears to be a date error in the source. The mismatch between the code's nominal scope and the pharmaceutical categories actually being bought suggests that this code may see limited direct activity for sulnidazole procurement; vendors should verify code alignment with specific issuing bodies before pursuing opportunities tagged under this classification.